I am Tucker Veach
I have been litigating commercial and securities matters since 1983. First in Houston, then in D.C., I had the opportunity to work with some of the nation’s most gifted leaders pinioned at the intersection of high finance and investment and legal thought. These lawyers included a former General Counsel at the SEC, whom I had the privilege of working for a number of years. I have represented clients in the finance and investment sphere for 20 years.
My focus in the area of investment disputes was triggered by a case that involved three elderly couples and an elderly widow who were defrauded by their highly trusted stockbroker. The experience broke their lives in so many ways; first financially, then socially, ultimately stealing their faith and hope. It was heart wrenching and intolerable. While working at two large law firms I was involved in cases concerning hundreds of millions of dollars, but handing a check representing the return of a substantial part of their investment losses to Mr. and Mrs. Bridgers (age 92 and 90) is still the most satisfying moment of my career.
What We Do
All the services you need, all in one place.
Fighting for people damaged by the misconduct has been a career-long calling. Helping people restore their lives is an accomplishment for which I am each time proud. I am driven to help those who find themselves lost and broken at the hands of trusted representatives like brokers and financial advisers. I hold it an honor to have recovered tens of millions of dollars on behalf of investors. Over the years we have represented hundreds of individuals and entities alike in matters before the SEC, the FDIC, and FINRA through investigations and arbitration.
Small firm appeal. Large firm privilege.
Fraudulent Leasing Program
Represented 375 investors in state and federal actions relating to a fraudulent leasing program, collecting over $7 million for the investors.
Represented investor class in class action against a major law firm, collecting over $2.5 million.
Represented 60 individuals in an insurance Ponzi scheme and obtained a $9.5 million jury verdict.
Fraudulent Investment Offerings
Represented 47 individuals against a major Life Insurance company regarding a fraudulent investment offering, collecting over $5 million for the investors.
Premature Termination of Fund
Represented investor class in class action against mutual fund family regarding premature termination of a fund, collecting over $3 million for the investors.
Represented hundreds of individuals in arbitration and court proceedings relating to investments, collecting over $30 million dollars for the investors.
Corporate SEC Investigations
Represented “Inc. 100” corporation in SEC investigation, threatened delisting by the NASDAQ and class action securities litigation.
Officer SEC Investigation
Represented former Chief Operating Officer of major corporation and his family in an investigation by the SEC.
SEC Investigations and International Corporations
Represented Canadian corporation in SEC investigation, threatened delisting by the American Stock Exchange and application to the NASDAQ Stock Market, Inc.
Represented the Federal Deposit Insurance Corporation connected with the failure of a savings and loan associations, resulting in multimillion dollar judgments against culpable officers and directors.
Conducted an extensive investigation of potential securities law violations in connection with the operation by a brokerage firm of a “covered call” options program for the savings and loan association.
Represented a Fortune 100 company in an action contesting the sale of three $200 million vessels; the action proceeded simultaneously in administrative and judicial forums to a very successful negotiated settlement.
Government Agency Contracts
Litigated numerous cases involving contracts with government agencies, including several cases before the General Services Board of Contract Appeals.
Represented the inventor of drug compounds that have received national attention in contract negotiations with the inventor’s research hospital and with pharmaceutical companies interested in obtaining licenses for the compounds.